Covered recipient · General Payments record
JOY L BARNES
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2021
$829.36
- Reported across 61 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2021 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $366.15 | 29 |
By paying entity
PY2021 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $148.61 | 14 |
| PFIZER INC. | $82.87 | 5 |
| Novo Nordisk AS | $55.84 | 4 |
| Lilly USA, LLC | $24.95 | 2 |
| Adlon Therapeutics L.P. | $14.79 | 1 |
| Daiichi Sankyo Inc. | $14.58 | 1 |
| DEXCOM, INC. | $13.29 | 1 |
| Teva Pharmaceuticals USA, Inc. | $11.22 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2021 (29)
Sorted by paying entity, then date · as published by CMS
Program year 2021 201820192020
Record-level detail is published for PY2021; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AbbVie Inc. | $14.63 | 02/03/2021 | Food and Beverage | Undisputed | 01/23/2026 | 793991221 | CMS |
| AbbVie Inc. | $8.68 | 03/03/2021 | Food and Beverage | Undisputed | 01/23/2026 | 793991225 | CMS |
| AbbVie Inc. | $9.50 | 03/10/2021 | Food and Beverage | Undisputed | 01/23/2026 | 793991229 | CMS |
| AbbVie Inc. | $4.69 | 03/18/2021 | Food and Beverage | Undisputed | 01/23/2026 | 793991233 | CMS |
| AbbVie Inc. | $14.64 | 03/29/2021 | Food and Beverage | Undisputed | 01/23/2026 | 793991237 | CMS |
| AbbVie Inc. | $13.89 | 04/14/2021 | Food and Beverage | Undisputed | 01/23/2026 | 793991241 | CMS |
| AbbVie Inc. | $10.54 | 04/21/2021 | Food and Beverage | Undisputed | 01/23/2026 | 793991245 | CMS |
| AbbVie Inc. | $11.40 | 05/05/2021 | Food and Beverage | Undisputed | 01/23/2026 | 793991249 | CMS |
| AbbVie Inc. | $11.84 | 05/13/2021 | Food and Beverage | Undisputed | 01/23/2026 | 793991253 | CMS |
| AbbVie Inc. | $10.41 | 05/19/2021 | Food and Beverage | Undisputed | 01/23/2026 | 793991257 | CMS |
| AbbVie Inc. | $14.72 | 05/24/2021 | Food and Beverage | Undisputed | 01/23/2026 | 793991261 | CMS |
| AbbVie Inc. | $10.04 | 06/16/2021 | Food and Beverage | Undisputed | 01/23/2026 | 793991265 | CMS |
| AbbVie Inc. | $1.23 | 07/12/2021 | Food and Beverage | Undisputed | 01/23/2026 | 793991269 | CMS |
| AbbVie Inc. | $12.40 | 07/12/2021 | Food and Beverage | Undisputed | 01/23/2026 | 793991273 | CMS |
| Adlon Therapeutics L.P. | $14.79 | 01/20/2021 | Food and Beverage | Undisputed | 01/23/2026 | 844821597 | CMS |
| Daiichi Sankyo Inc. | $14.58 | 05/12/2021 | Food and Beverage | Undisputed | 01/23/2026 | 836290185 | CMS |
| DEXCOM, INC. | $13.29 | 04/26/2021 | Food and Beverage | Undisputed | 01/23/2026 | 845269343 | CMS |
| Lilly USA, LLC | $12.39 | 04/07/2021 | Food and Beverage | Undisputed | 01/23/2026 | 818615441 | CMS |
| Lilly USA, LLC | $12.56 | 06/02/2021 | Food and Beverage | Undisputed | 01/23/2026 | 818616267 | CMS |
| Novo Nordisk Inc | $15.65 | 01/06/2021 | Food and Beverage | Undisputed | 01/23/2026 | 810634651 | CMS |
| Novo Nordisk Inc | $14.57 | 02/10/2021 | Food and Beverage | Undisputed | 01/23/2026 | 811578827 | CMS |
| Novo Nordisk Inc | $13.75 | 07/01/2021 | Food and Beverage | Undisputed | 01/23/2026 | 811435051 | CMS |
| Novo Nordisk Inc | $11.87 | 10/13/2021 | Food and Beverage | Undisputed | 01/23/2026 | 811435055 | CMS |
| PFIZER INC. | $15.86 | 02/11/2021 | Food and Beverage | Undisputed | 01/23/2026 | 832706391 | CMS |
| PFIZER INC. | $16.91 | 04/08/2021 | Food and Beverage | Undisputed | 01/23/2026 | 833446119 | CMS |
| PFIZER INC. | $14.11 | 07/07/2021 | Food and Beverage | Undisputed | 01/23/2026 | 832611423 | CMS |
| PFIZER INC. | $12.82 | 07/21/2021 | Food and Beverage | Undisputed | 01/23/2026 | 833545707 | CMS |
| PFIZER INC. | $23.17 | 12/07/2021 | Food and Beverage | Undisputed | 01/23/2026 | 833165065 | CMS |
| Teva Pharmaceuticals USA, Inc. | $11.22 | 05/03/2021 | Food and Beverage | Undisputed | 01/23/2026 | 839633857 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021
- Generated from
- OP_DTL_GNRL_PGYR2021_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.